Reporting owner · Q3 2026 · CIK 1971187

Taich Adam: insider trades.

Taich Adam reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($4.1M), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
Taich Adam

Companies

CompanyRelationshipTransactions
10x Genomics, Inc. (TXG)Officer · Chief Financial Officer4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-0910x Genomics, Inc.S1,206$63.68361,526Form 4
2026-09-0910x Genomics, Inc.S13,754$65.26316,344Form 4
2026-09-0910x Genomics, Inc.S31,428$64.31330,098Form 4
2026-08-2410x Genomics, Inc.S17,166$63.02362,732Form 4

Questions

What stock did Taich Adam buy or sell?

Taich Adam reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($4.1M), across 1 company.

Is Taich Adam the same person as other filers with this name?

This page covers SEC CIK 1971187 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/taich-adam-1971187.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.